The landscape of therapeutic drugs is undergoing a transformative phase, driven by significant strides in bioprocessing technologies and innovative biotechnological advancements. One of the most notable developments in recent years has been the shift towards personalized medicine, which tailors
Mirror bacteria, theoretical organisms composed of chiral molecules that are mirror images of those found in natural life forms, have sparked significant debate within the scientific community. These organisms hinge on the concept of chirality, where "right-handed" amino acids and
The field of immunotherapy has witnessed a groundbreaking advancement with the introduction of TRACeR-I, a novel protein platform designed to enhance antigen recognition. This innovative platform promises broad HLA compatibility, significantly improving immune response engineering and targeting
A consortium of 38 leading scientists spanning various disciplines has issued a stark warning regarding the potential creation of “mirror bacteria” – synthetic organisms with reversed molecular structures. This concept, while seemingly out of a science fiction plot, poses significant risks that coul
MilliporeSigma, the Life Science business of Merck KGaA in the U.S. and Canada, has announced a definitive agreement to acquire HUB Organoids Holding B.V. (HUB). This acquisition marks a significant step forward in enhancing their 2D and 3D cell culture portfolio with the innovative technology of
In the ever-evolving field of biotechnology, cell and gene therapy offer unprecedented potential to treat diseases once considered untreatable. However, recent evidence suggests that the conventional methods of culturing cells might be hindering progress. Researchers are now reconsidering the
